Establishment Labs Holdings Inc. (ESTA): Price and Financial Metrics


Establishment Labs Holdings Inc. (ESTA)

Today's Latest Price: $27.17 USD

0.67 (2.53%)

Updated Nov 27 1:00pm

Add ESTA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

ESTA Stock Summary

  • Establishment Labs Holdings Inc's stock had its IPO on July 19, 2018, making it an older stock than merely 6.14% of US equities in our set.
  • ESTA's price/sales ratio is 7.77; that's higher than the P/S ratio of 81.57% of US stocks.
  • Establishment Labs Holdings Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -10.15%, greater than the shareholder yield of only 23.4% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Establishment Labs Holdings Inc are OPTN, STIM, VAPO, PWFL, and TELA.
  • Visit ESTA's SEC page to see the company's official filings. To visit the company's web site, go to www.establishmentlabs.com.

ESTA Stock Price Chart Interactive Chart >

Price chart for ESTA

ESTA Price/Volume Stats

Current price $27.17 52-week high $29.78
Prev. close $26.50 52-week low $7.56
Day low $26.54 Volume 20,500
Day high $27.17 Avg. volume 84,875
50-day MA $22.25 Dividend yield N/A
200-day MA $18.56 Market Cap 636.81M

Establishment Labs Holdings Inc. (ESTA) Company Bio


Establishment Labs Holdings Inc., a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. The company was founded in 2004 and is based in Alajuela, Costa Rica.


ESTA Latest News Stream


Event/Time News Detail
Loading, please wait...

ESTA Latest Social Stream


Loading social stream, please wait...

View Full ESTA Social Stream

Latest ESTA News From Around the Web

Below are the latest news stories about Establishment Labs Holdings Inc that investors may wish to consider to help them evaluate ESTA as an investment opportunity.

Establishment Labs Holdings Inc. (ESTA) CEO Juan José Chacón-Quirós on Q2 2020 Results - Earnings Call Transcript

Establishment Labs Holdings Inc. (ESTA) Q2 2020 Earnings Conference Call August 06, 2020 5:30 PM ET Company Participants David Erickson – Vice President, Investor Relations Juan José Chacón-Quirós – Chief Executive Officer Renee Gaeta – Chief Financial Officer Conference Call Participants Raj Denhoy – Jefferies Josh Jennings – Cowen Amit...

SA Transcripts on Seeking Alpha | August 8, 2020

Earnings Preview: Establishment Labs Holdings Inc. (ESTA) Q2 Earnings Expected to Decline

Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 30, 2020

Establishment Labs to Announce Second Quarter 2020 Financial Results on August 6

NEW YORK, July 23, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA), a medical technology company focused on Women’s Health,…

GlobeNewswire | July 23, 2020

Hedge Funds Have Never Been This Bullish On Establishment Labs Holdings Inc. (ESTA)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of March 31st, 2020. […]

Yahoo | June 27, 2020

Establishment Labs’ Motiva Flora Tissue Expander Receives CE Mark

Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has received CE Mark for the Motiva Flora Tissue Expander. “Unlike traditional tissue expanders with magnetic ports, a patient with a Motiva Flora Tissue Expander can be safely scanned immediately after placement using MR systems operating at 1.5- or 3-Tesla,” said Frank G. Shellock, Ph.D., Adjunct Clinical Professor of Radiology and Medicine, and Director of MRI Safety, University of Southern California, and author of the widely used Reference Manual for Magnetic Resonance Safety, Implants, and Devices.

Yahoo | June 11, 2020

Read More 'ESTA' Stories Here

ESTA Price Returns

1-mo 8.55%
3-mo 48.71%
6-mo 33.84%
1-year 12.55%
3-year N/A
5-year N/A
YTD -1.77%
2019 0.88%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Continue Researching ESTA

Here are a few links from around the web to help you further your research on Establishment Labs Holdings Inc's stock as an investment opportunity:

Establishment Labs Holdings Inc (ESTA) Stock Price | Nasdaq
Establishment Labs Holdings Inc (ESTA) Stock Quote, History and News - Yahoo Finance
Establishment Labs Holdings Inc (ESTA) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7377 seconds.